MENU
HQL
ETF ticker: NYSE
PRICE
CHANGE
NET ASSETS

HQL stock forecast, quote, news & analysis

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company... Show more

HQL
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for HQL with price predictions
Oct 01, 2026

Momentum Indicator for HQL turns negative, indicating new downward trend

HQL saw its Momentum Indicator move below the 0 level on September 01, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned negative. In 72 of the 82 cases, the stock moved further down in the following days. The odds of a decline are at 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for HQL turned negative on August 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 39 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.

HQL moved below its 50-day moving average on September 10, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for HQL crossed bearishly below the 50-day moving average on September 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HQL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for HQL entered a downward trend on October 01, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for HQL's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where HQL advanced for three days, in 273 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

HQL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
published Highlights

Industry description

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund’s Investment Adviser to have the potential for above-average growth.

Volume

The average weekly volume growth across all stocks in the abrdn Life Sciences Investors ETF was -3%. For the same stocks of the ETF, the average monthly volume growth was -23% and the average quarterly volume growth was -1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 31
Price Growth Rating: 37
SMR Rating: 57
Profit Risk Rating: 64
Seasonality Score: 11 (-100 ... +100)
View a ticker or compare two or three
HQL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Unknown

Category
Health
Address
2 Liberty Square9th FloorBoston
Phone
N/A
Web
https://www.teklacap.com/funds/hql/fund/fund-information/